Alka Batycky - 30 May 2023 Form 3 Insider Report for Landos Biopharma, Inc.

Role
Director
Signature
/s/ Gregory Oakes, attorney-in-fact
Issuer symbol
N/A
Transactions as of
30 May 2023
Net transactions value
$0
Form type
3
Filing time
01 Jun 2023, 16:19:36 UTC
Next filing
23 May 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney No securities are beneficially owned.